Skip to content

The effect of intraoperative infusion of esketamine on early sleep disorders in patients after thoracoscopic lung resection: A prospective, randomized controlled study

The effect of intraoperative infusion of esketamine on early sleep disorders in patients after thoracoscopic lung resection: A prospective, randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118866
Enrollment
Unknown
Registered
2026-02-12
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sleep disorder

Interventions

experimental group:30 minutes before the end of the surgery, an initial dose of esketamine at 0.2mg/kg (10ml) was administered intravenously. Subsequently, a continuous intravenous analgesia pump was
control group:Thirty minutes before the end of the surgery, an equal volume (10ml) of normal saline was infused at the same rate. Then, a venous analgesia pump was used to provide pain relief. The con

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–75 years; 2. ASA grade I–III; 3. BMI between 18.5 and 30 kg/m²; 4. Thoracoscopic pulmonary resection; 5. No preoperative sleep disturbance, with a preoperative AIS score <6 (0–5 points).

Exclusion criteria

Exclusion criteria: 1. Patients who refuse to participate in the study; 2. Preoperative AIS score >=6, indicating preoperative sleep disturbance; 3. Undergoing emergency surgery; 4. Allergy or contraindication to esketamine; 5. History of psychiatric disorders or long-term use of medication for psychological illnesses; 6. History of alcohol or substance abuse; 7. Severe sensory organ deficits (e.g., visual or hearing impairment), cognitive dysfunction, or inability to communicate normally.

Design outcomes

Primary

MeasureTime frame
The incidence of sleep disorders within 3 days after the surgery;

Secondary

MeasureTime frame
Sleep efficiency within 3 days after surgery, percentage of rapid eye movement sleep, percentage of unstable sleep, percentage of stable sleep, and number of awakenings;The pain condition and the amount of opioid consumption three days after the surgery;The levels of anxiety and depression within 3 days after the surgery;The recovery status within 3 days after the operation;Postoperative adverse reactions;Postoperative hospital stay duration;

Countries

China

Contacts

Public ContactZhou Huidan

Anesthesiology Department of Zhejiang Cancer Hospital

zhouhd@zjcc.org.cn+86 138 5803 7535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026